Is behavioral science key to patient-focused drug development?
Last year, Astellas Pharma established a behavioral science consortium to perform research aimed at better understanding what matters to patients
READ MOREJuly 4, 2024
Last year, Astellas Pharma established a behavioral science consortium to perform research aimed at better understanding what matters to patients
READ MOREThis first-of-its-kind phase 2 grant will expedite the commercialization of cannabinoid ingredient production via precision fermentation. The funding aims to
READ MOREHowever, the eCOA/ePRO market has seen minimal innovation since the transition from paper-based forms to digital formats two decades ago,
READ MORESpectrum supports study teams by providing real-time predictions and control over trial timelines and costs, ensuring successful trials in today’s
READ MOREThis key study explores the influence of CYP2C9 genetic polymorphisms on the pharmacokinetics (PK) of delta-9-tetrahydrocannabinol (THC) and its active
READ MOREThe conversation delves into the complexities of signal management in the PV landscape, highlighting recent advancements and the challenges faced
READ MORECluePoints is a cloud-based software platform specializing in Risk-Based Quality Management (RBQM) and data quality oversight in clinical trials. The
READ MOREThis guideline, which ensures regulatory compliance with the requirements of ICH GCP E6, came into effect on 9 September 2023.
READ MOREThis expansion of Thermo Fisher’s clinical trial network in Europe will help foster global clinical trial innovation and provide biorepository
READ MOREThis key study explores the influence of CYP2C9 genetic polymorphisms on the pharmacokinetics (PK) of delta-9-tetrahydrocannabinol (THC) and its active
READ MORE